Hypoxia-Inducible Factor-1 in Physiological and Pathophysiological Angiogenesis: Applications and Therapies
Open accessThe DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Abstract
The cardiovascular system ensures the delivery of oxygen and nutrients to all cells, tissues, and organs. Under extended exposure to reduced oxygen levels, cells are able to survive through the transcriptional activation of a series of genes that participate in angiogenesis, glucose metabolism, and cell proliferation. The oxygen-sensitive transcriptional activator HIF-1 (hypoxia-inducible factor-1) is a key transcriptional mediator of the response to hypoxic conditions. The HIF-1 pathway was found to be a master regulator of angiogenesis. Whether the process is physiological or pathological, HIF-1 seems to participate in vasculature formation by synergistic correlations with other proangiogenic factors such as VEGF (vascular endothelial growth factor), PlGF (placental growth factor), or angiopoietins. Considering the important contributions of HIF-1 in angiogenesis and vasculogenesis, it should be considered a promising target for treating ischaemic diseases or cancer. In this review, we discuss the roles of HIF-1 in both physiological/pathophysiological angiogenesis and potential strategies for clinical therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Schematic representation of HIF-α gene structures and DNA binding. (a) HIF-1α and HIF-2α contain the following domains: a nuclear localisation domain (NLS), DNA binding and dimerisation domains (bHLH/PAS), oxygen-dependent degradation domain (ODDD), and cofactor interaction and transcriptional activity domains (N-TAD/C-TAD). HIF-3α lacks a C-TAD domain. NLS: nuclear localisation signal; bHLH: basic helix-loop-helix domain; PAS: Per-ARNT-Sim motif; ODDD: oxygen-dependent degradation domain; N-TAD: N-terminal transactivation domain; C-TAD: C-terminal transactivation domain. (b) Dimerisation of HIF-1α with HIF-1β under hypoxic conditions results in the formation of the HIF-1 transcription factor, which binds to hypoxia response elements (HREs) and activates the transcription of O2-dependent genes (according to [134]).](https://figures.cochat.ai/paper-figures/7f1eff6f4e4b425f9d8561e5e5c9be64/hypoxia-inducible-factor-1-in-physiological-and-pathophysiological-angiogenesis-figure-1.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the normal developmental setting, HIF-1α plays a dominant role throughout vasculogenesis, whereas HIF-2α contributes primarily to vessel remodeling and maturation during the later stages of vasculogenesis (the HIF switch) [25].”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [25]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Characteristics of tumor vasculature include lack of stabilization by pericytes and smooth muscle cells and a lack of an arterial or venous phenotype that leads to leakage, poor blood flow and perfusion (Figure 3) [25].”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Risau, W. (1997) · Nature · doi:10.1038/386671a0 · Cited by 5,727 · cited 2×
“Because the uterine environment is hypoxic it is thereby obvious that hypoxiamay be the primary stimulus of vessel formation [3, 4].”
BackgroundMolecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
Angiogenesis in health and disease
Carmeliet, P. (2003) · Nature Medicine · doi:10.1038/nm0603-653 · Cited by 4,276 · cited 1×
“growth factors that activate their receptors [5, 6].”
Mechanisms of angiogenesis and arteriogenesis
Carmeliet, P. (2000) · Nature Medicine · doi:10.1038/74651 · Cited by 4,162 · cited 1×
“Vessel formation occurs via only two basicmechanisms: vasculogenesis and angiogenesis [2].”
BackgroundActivation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981
Vascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
Research works printed but not linked: 1
- Folkman J. Holland J. F. Bast R. C. Jr. Morton D. L. Frei E. III Kufe D. W. Weichselbaum R. R. Tumour angiogenesis Cancer Medicine 1997 Baltimore, Md, USA Williams & Wilkins 181 204
Cited by
Items 601–650 of 650
Σπύρου, Ν. Γ., & Σπύρου, Ν. Γ. (2024) · University of Thessaly Institutional Repository (University of Thessaly) · doi:10.26253/heal.uth.41444
Невзорова, В. А., Волосатов, А. С., Владимировна, Т. А., Музыченко, Н. С., Дубов, В. С., & Черток, В. М. (2025) · Pacific Medical Journal · doi:10.34215/1609-1175-2025-3-11-20
Orǎșanu, C. I., Boşoteanu, M., Vameşu, S., Vodă, R. I., Sincu, A., & Deacu, M. (2025) · Medical Sciences · doi:10.3390/medsci14010006
“Consequently, necrotic phenomena occur as a consequence of the newly formed vessels’ inability to sustain the demand for oxygen and nutrients [5,43–45].”
Sheenam, N., Gaur, R., Abins, T. K., & Beegum, S. (2026) · Indian Journal of Physical Medicine and Rehabilitation · doi:10.4103/ijpmr.ijpmr_29_25
Wang, R., Wang, F., Xu, Y., Sun, W., Jiang, P., Guo, Y., & Yu, Q. (2026) · Cancer Management and Research · doi:10.2147/cmar.s546059
“72 Hydrolysis of the Bid protein of caspase-8 produces t-Bid, which goes on to induce the release of cytochrome c that which in turn promotes protein hydrolysis and activation of caspase-8, closing the vicious circle.”
Antiangiogenic miRNA-Based Combination Therapy
Agarwal, P., Patil, J., Bhatia, D. D., & Yadav, A. K. (2026) · Springer eBooks · doi:10.1007/978-981-95-5989-3_13
HIF-1α ameliorates myocardial apoptosis and promotes angiogenesis in diabetic myocardial infarction
Mai, L., He, W., Pan, Y., Zhan, H., Xu, L., Wu, X., & Li, M. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.117906
Über die Rolle der Cryptochrome in Karzinogenese und Therapieresitenz des kolorektalen Karzinoms
Malz, L. (2026) · heiDOK (Heidelberg University) · doi:10.11588/heidok.00038282
Griseti, E. (2020) · theses.fr (ABES) · doi:10.70675/57c1a8a7zadbaz40d3zb8baze25015dbc60e · Cited by 1
Lung responses to radiation injury at the single cell level
Curras-Alonso, S. (2021) · theses.fr (ABES) · doi:10.70675/fddace61zeaf6z49a7zbc1fzb7b3ddd6f261 · Cited by 1
Gharzeddine, K. (2022) · theses.fr (ABES) · doi:10.70675/7d07ca5fz8f2dz429az8ad4z0a9323021529 · Cited by 1
Yegen, C.-H. (2021) · theses.fr (ABES) · doi:10.70675/000be83bz719fz4984z8d30zd055436e0b2e
Développement d'un ciblage moléculaire et d'un ciblage nanoparticulaire des dysfonctions vasculaires
Louis, B. (2022) · theses.fr (ABES) · doi:10.70675/4213c176z0905z4638z8db3z7ea83befc80b
Multifaceted role of CNPY2 beyond ER stress: Disease implications and therapeutic potential
Ebadollahibaruq, S., Meng, L., & Hong, F. (2026) · Cell Stress · doi:10.15698/cst2026.03.316
“In re-sponsetohypoxia-inducedischemicinjury, CNPY2upregulates HIF-1 𝛼 and vascular endothelial growth factor (VEGF), enhancing revascularization, smooth muscle cell migration and proliferation [14,49,80].”
Li, Y., Lv, S., & Wang, Y. (2026) · BMC Cancer · doi:10.1186/s12885-026-16132-w
“Copper content was positively associated with the expression of hypoxia-inducible factor ⁃ 1α (HIF ⁃ 1α) [36, 37], which can increase the abundance of VEGF, leading to rapid angiogenesis of tumor [38].”
Zalozniaia, I. V., Milyutina, Y. P., Arutjunyan, A. V., Mikhel, A. V., Gorbova, A. V., Валентинович, К. А., & Bespalova, O. N. (2026) · Neurochemical Journal · doi:10.1134/s1819712426700054
Liu, B., Liu, J., Wang, L., Liu, C., & Song, L. (2026) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2026.105640
Li, H.-Y., Peng, M.-Z., Tang, L.-H., Li, J.-A., Jin, Y., Liang, L. I. U., & Wang, W.-Q. (2026) · Seminars in Oncology · doi:10.1016/j.seminoncol.2026.152505
Angiogenic Gene Therapy for Lower Extremity Ischemia: Experimental Advances and Clinical Experience
Саматошенков, И. В., Zakirova, E. Y., Samatoshenkova, J. M., Rizvanov, A. A., & Mukhamedshina, Y. O. (2026) · Cells · doi:10.3390/cells15121104 · Cited by 1
“…elements (HREs) in gene promoters and activates the transcription of numerous angiogenic factors, including VEGF-A, FGF-2, ANGPT, and SDF-1/CXCL12, thereby promoting endothelial cell proliferation and migration, tubular structure formation, and recruitment of EPCs to ischemic sites [91,92].”
Dümür, Ş., Asl, M. M. B., Aygün, D., Konukoğlu, D., & Uzun, H. (2026) · Biomedicines · doi:10.3390/biomedicines14071458
“HIF-1 HIF-1 α is the principal transcription factor regulating cellular adaptation to hypoxic stress and coordinates the expression of genes involved in angiogenesis, glucose utilization, oxidative stress responses, and vascular remodeling [9,10,27,28].”
Wei, Y., Xie, X., Hou, X., Li, D., Hou, J., & Gao, Y. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1793851
“So repeatedly, there forms a vicious cycle like “hypoxia-FLS/VEC proliferation-angiogenesis-hypoxia ... ” (Zimna and Kurpisz, 2015).”
Izquierdo-Serrano, R., Sharysh, D., Cumbicus, V., Hernansanz‐Agustín, P., Sluimer, J. C., Martín-Puig, S., Carramolino, L., Morales‐Cano, D., & Bentzon, J. F. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.26.734925
“In macrophages, HIF1α exacerbates disease by promoting inflammation and foam cell formation, 45 whereas in endothelial cells it facilitates neovascularization and monocyte recruitment, 6,46 and in dendritic cells and T cells, by contrast, it exerts a protective effect.”
Sanabria, C. S. J., & Vera Villalobos, J. R. (2026) · Maestría en Control de Operaciones y Gestión Logística (Escuela Superior Politécnica del Litoral)
Dağar, O., ÇELİK, Z., Tural, A., Yaka, C., ÖNER, M., & Tuzcu, M. (2026) · Revista Científica de la Facultad de Ciencias Veterinarias · doi:10.52973/rcfcv-e363960
Akl, M. M., & Ahmed, A. (2026) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2026.1897413
Uruski, P., Mikuła‐Pietrasik, J., Tykarski, A., & Książek, K. (2026) · Journal of Hypertension · doi:10.1097/hjh.0000000000004391
“While the study assessed markers of cellular ageing, this did not include a direct evaluation of apoptosis.”
Boulis, M., Tawfik, F., & Shenoy, A. K. (2026) · Cells · doi:10.3390/cells15141295
“Central to this process is the requirement of prolyl-hydroxylation (PHD) of HIF-α , which serves as the molecular gate for VHL-mediated proteasomal degradation [78–80].”
DISSECTING THE ROLE OF REACTIVE OXYGEN SPECIES IN EARLY MAMMALIAN EMBRYOGENESIS
Lodde, V., Ceciliani, F., & Bonumallu, S. K. N. (2025) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano)
Hesaraki, M., Haghdoost, F., Mashhadi, B., Zadeh, A. N., & Sarafrazi, F. (2026) · Biomedicine Advances · doi:10.34172/bma.79
Jiménez-Flores, E., Reytor-González, C., Gavilanes, D. J., Rossetti, G., Pilone, V., Parrillo, L., Cavallo, M., Cobellis, L., Simancas-Racines, D., & Schiavo, L. (2026) · Nutrients · doi:10.3390/nu18183075
“Hypoxia—a hallmark of hypertrophic AT– activates hypoxia-inducible factor 1 alpha (HIF-1 α ), which in turn induces expression of pro-angiogenic factors such as vascular endothelial growth factor (VEGF) [30].”
Leveraging exosomes and lipid nanoparticles based nanomedicine for cervical cancer therapeutics
Ghosh, D., Gupta, P., Kumar, V., Kumar, A., Ahirwar, A. K., Sahoo, P. K., & Thakur, A. (2026) · Next Nanotechnology · doi:10.1016/j.nxnano.2026.100786
Domka, W., Misiołek, M., Raj, D. R. J., Bartusik‐Aebisher, D., Myśliwiec, A., & Aebisher, D. (2026) · Biomedicines · doi:10.3390/biomedicines14092103
“This forms a link between oxygen sensing and vascular growth as the HIF system combines angiogenic signalling with the local oxygen demand [34].”
Darwish, F. M. A. (2026) · UvA-DARE (University of Amsterdam)
Observation or treatment of paediatric varicoceles: revisiting the evidence
Buchinsky, D. S., Naelitz, B. D., Siva, J., Vallabhaneni, S., Momtazi-Mar, L., Klock, J. A., Hannick, J. H., Lundy, S. D., Weaver, J. K., & Woo, L. L. (2026) · Nature Reviews Urology · doi:10.1038/s41585-026-01187-y
Li, S., Liu, Y., Yan, H., Zhou, X., Liu, Q., Waheed, Y. A., Wang, D., & Sun, D. (2026) · PLoS ONE · doi:10.1371/journal.pone.0359419
Ahn, B., Min, K. A., & Yang, J. (2026) · Scientific Reports · doi:10.1038/s41598-026-73627-z
León‐Arcia, K., Martínez-Orozco, H., Crespo, M., Díaz-Cintra, S. Y., & Soto-Rojas, L. O. (2026) · Journal of Molecular Neuroscience · doi:10.1007/s12031-026-02610-0
“Reduced cerebral blood flow and elevated hypoxia-inducible factor-1 alpha (HIF-1α) induce the transcription of VEGF and angiopoietin-2, which, while attempting to compensate for ischemia, can generate imma - ture and leaky vessels (Qin et al. 2013; Zimna and Kurpisz 2015 ).”
Gaviglio, C. M., Cook, C. J., & Bird, S. P. (2026) · Journal of Functional Morphology and Kinesiology · doi:10.3390/jfmk11040423
“In the IIC training groups only, increases were observed in hypoxia-inducible factor-1 α (HIF-1 α ), implicating activation of angiogenic pathways, and Ki-67, indicating increased cellular proliferation associated with capillary expansion and muscle remodeling [62,63].”
Karisa, P., Sylviana, N., Rosdianto, A. M., Goenawan, H., Syamsunarno, M. R. A. A., & Setiawan, I. (2026) · Cardiology Research and Practice · doi:10.1155/crp/2976039
“Traditionally, HIF-1 α has been regarded as the principal oxygen-sensitive regulator of angiogenesis because it stimulates transcription of VEGF during reduced tissue oxygen availability [17].”
Gautam, A., Timalsina, B. K., Chaulagain, R., & Bindal, U. (2026) · Medical Journal of IOSAT · doi:10.68003/mjiosat.v1i2.20
Liu, W., Lu, Y., Chen, J., Lv, Y., & 瓦庆德 (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1919568
Investigation du rôle de pikfyve dans la progression tumorale des carcinomes rénaux
Cormier, J. (2024) · ScriptoriUM
SRC-2 Regulates Brain Endothelial and Neuronal Metabolism in a Mouse Model of Neurodegeneration
Srivastava, R. K., Singh, P., Jonsson, E. S., Saleem, I., Desales, C. J. P., & Lonard, D. M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27219943
Kulkarni, S. S., Shah, A., Kumar, B. V., Srivastava, N., & Meher, N. (2026) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6c00880
Metadata
- Authors
- Zimna, A., & Kurpisz, M.
- Affiliations
- Institute of Human Genetics (PL)
- Corresponding author
- Kurpisz, Maciej
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2015
- Volume
- 2015
- Pages
- 1-13
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- PMC
- PMC4471260
- OpenAlex
- W1597158509
- Cited by
- 604
- References
- 138
- Citations by year
- 2026: 40 · 2025: 66 · 2024: 88 · 2023: 78 · 2022: 67 · 2021: 79 · 2020: 64 · 2019: 45 · 2018: 22 · 2017: 28 · 2016: 23 · 2015: 3
- FWCI
- 2.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- BioMed Research International (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Science Centre, Poland (2012/07/N/NZ3/01687, 2014/13/B/NZ3/04646, STRATEGMED1/233624/5/NCBR/2014)
- National Centre for Research and Development (2012/07/N/NZ3/01687, 2014/13/B/NZ3/04646, STRATEGMED1/233624/5/NCBR/2014)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Keywords
- HIF-1, angiogenesis, hypoxia, vascular endothelial growth factor, placental growth factor, angiopoietins, vasculogenesis, ischemic diseases, cancer, oxygen sensing, transcriptional regulation
- MeSH terms
- Placenta Growth Factor, Hypoxia, Humans, Neovascularization, Pathologic, Pregnancy Proteins, Transcriptional Activation, Cell Hypoxia, Neovascularization, Physiologic, Vascular Endothelial Growth Factor A, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.